The Rationale for Revising the Clinical and Laboratory Standards Institute Vancomycin Minimal Inhibitory Concentration Interpretive Criteria for Staphylococcus aureus
Authors:
- Fred C. TenoverFTFred C. Tenover
- R. C. MoelleringRMR. C. Moellering
Top Cited Papers
Open Access
- 1 May 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (9) , 1208-1215
Abstract
The Clinical and Laboratory Standards Institute (formerly, the NCCLS) established the susceptibility and resistance breakpoints for minimal inhibitorKeywords
This publication has 42 references indexed in Scilit:
- Isolation in Brazil of NosocomialStaphylococcus aureusWith Reduced Susceptibility to VancomycinInfection Control & Hospital Epidemiology, 2001
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50Antimicrobial Agents and Chemotherapy, 2000
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Vancomycin‐ResistantStaphylococcus aureus: Infection Control ConsiderationsClinical Infectious Diseases, 1998
- Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50Journal of Antimicrobial Chemotherapy, 1998
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- THE DRAMA.The Lancet, 1823